US5151439A
(en)
*
|
1990-05-04 |
1992-09-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
US5089514A
(en)
*
|
1990-06-14 |
1992-02-18 |
Pfizer Inc. |
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
|
TW222626B
(pt)
|
1991-07-22 |
1994-04-21 |
Pfizer |
|
US5498621A
(en)
*
|
1992-05-01 |
1996-03-12 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
SK695A3
(en)
*
|
1992-07-03 |
1995-07-11 |
Smithkline Beecham Plc |
Heterocyclic compounds method of their production and using
|
US5232945A
(en)
*
|
1992-07-20 |
1993-08-03 |
Pfizer Inc. |
3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
|
GB9225386D0
(en)
*
|
1992-12-04 |
1993-01-27 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311644D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311661D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9315148D0
(en)
*
|
1993-07-22 |
1993-09-08 |
Smithkline Beecham Plc |
Novel compounds
|
GB9326171D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Smithkline Beecham Plc |
Novel compounds
|
WO1996004261A1
(en)
*
|
1994-07-29 |
1996-02-15 |
Smithkline Beecham Plc |
Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
|
US5827865A
(en)
*
|
1995-03-09 |
1998-10-27 |
Smithkline Beecham P.L.C. |
Heterocyclic compounds as pharmaceutical
|
GB9604242D0
(en)
*
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
DK0916651T3
(da)
*
|
1996-04-04 |
2003-12-01 |
Sankyo Co |
Phenylalkylcarboxylsyrederivater
|
ATE277907T1
(de)
*
|
1996-07-01 |
2004-10-15 |
Lilly Co Eli |
Blutzuckersenkende und lipidsenkende verbindungen
|
IL121202A
(en)
|
1996-07-01 |
2001-08-26 |
Lilly Co Eli |
Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof
|
NZ334738A
(en)
|
1996-08-19 |
2001-01-26 |
Japan Tobacco Inc |
Pyridinyl or oxazolyl substituted phenyl-propionic acid derivatives
|
US6090839A
(en)
*
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
US6160000A
(en)
*
|
1996-12-23 |
2000-12-12 |
Merck & Co., Inc. |
Antidiabetic agents based on aryl and heteroarylacetic acids
|
WO1998028254A1
(fr)
*
|
1996-12-24 |
1998-07-02 |
Nippon Chemiphar Co., Ltd. |
Derives d'acide propionique
|
CN1168451C
(zh)
|
1997-06-18 |
2004-09-29 |
史密丝克莱恩比彻姆有限公司 |
噻唑烷二酮和磺酰脲组合物在制备治疗糖尿病的药物中的用途
|
EP0903343B1
(en)
*
|
1997-09-19 |
2003-05-28 |
SSP Co., Ltd. |
Alpha-Substituted phenylpropionic acid derivative and medicine containing the same
|
IL135177A0
(en)
|
1997-10-02 |
2001-05-20 |
Sankyo Co |
Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
CA2307068C
(en)
|
1997-10-27 |
2007-04-10 |
Dr. Reddy's Research Foundation |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
MXPA00004036A
(es)
|
1997-10-27 |
2006-05-24 |
Reddys Lab Ltd Dr |
Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen..
|
CN1280574A
(zh)
*
|
1997-10-27 |
2001-01-17 |
雷迪研究基金会 |
新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
|
JP2002501909A
(ja)
*
|
1998-01-29 |
2002-01-22 |
ドクター・レディーズ・リサーチ・ファウンデーション |
新規なアルカン酸およびその医薬における使用、並びにその製造方法、およびそれを含有する薬学的組成物
|
US6166069A
(en)
*
|
1998-05-12 |
2000-12-26 |
American Home Products Corporation |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
JP2002514636A
(ja)
*
|
1998-05-12 |
2002-05-21 |
アメリカン・ホーム・プロダクツ・コーポレイション |
インスリン抵抗性または高血糖症の治療に有用なフェニルオキソ−酢酸類
|
NZ504106A
(en)
*
|
1998-05-27 |
2003-02-28 |
Dr |
Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
|
SE9801992D0
(sv)
*
|
1998-06-04 |
1998-06-04 |
Astra Ab |
New 3-aryl-2-hydroxypropionic acid derivative I
|
MA26634A1
(fr)
|
1998-06-04 |
2004-12-20 |
Astra Ab |
Nouveaux derives de l'acide 3-aryl propionique et analogues
|
EP1087963B1
(en)
|
1998-06-19 |
2004-08-25 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
US7045519B2
(en)
*
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
GB9817118D0
(en)
|
1998-08-07 |
1998-10-07 |
Glaxo Group Ltd |
Pharmaceutical compounds
|
KR100613175B1
(ko)
*
|
1998-08-27 |
2006-08-17 |
오노 야꾸힝 고교 가부시키가이샤 |
카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제
|
US6589969B1
(en)
|
1998-10-16 |
2003-07-08 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
WO2000028989A1
(en)
|
1998-11-12 |
2000-05-25 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
DZ2937A1
(fr)
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
EP1171430A1
(en)
*
|
1999-04-16 |
2002-01-16 |
Dr. Reddy's Research Foundation |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
|
US6528507B1
(en)
|
1999-04-16 |
2003-03-04 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
WO2000063189A1
(en)
*
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
WO2000075117A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Elan Pharma International Ltd. |
Compositions and methods for inhibiting cell death
|
WO2001011072A1
(en)
*
|
1999-08-05 |
2001-02-15 |
Novo Nordisk A/S |
Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
|
US6617342B1
(en)
|
1999-08-27 |
2003-09-09 |
Eli Lilly And Company |
Hypoglycemic sulfonyl pyrazolones and pyrazolines
|
US6541495B1
(en)
|
1999-08-27 |
2003-04-01 |
Pfizer |
Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
|
CA2382966A1
(en)
|
1999-08-27 |
2001-03-08 |
Eli Lilly And Company |
Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
|
HU230609B1
(hu)
*
|
2000-01-19 |
2017-03-28 |
Cadila Healthcare Ltd. |
Hipolipidémiás és hipokoleszterinémiás hatású szubsztituált pirrolszármazékok, azokat tartalmazó gyógyszerkészítmények, eljárás előállításukra, köztitermékek és alkalmazásuk
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
GB0002667D0
(en)
*
|
2000-02-04 |
2000-03-29 |
Glaxo Group Ltd |
medicamesnts
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6908908B2
(en)
|
2000-05-12 |
2005-06-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Biologically active 4H-benzo [1,4] oxazin-3-ones
|
PT1280784E
(pt)
*
|
2000-05-12 |
2007-09-03 |
Ortho Mcneil Pharm Inc |
4h-benzo [1,4] oxazin-3-onas biologicamente activas.
|
EP1280783A2
(en)
*
|
2000-05-12 |
2003-02-05 |
Ortho-McNeil Pharmaceutical, Inc. |
Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
|
WO2001087860A2
(en)
*
|
2000-05-12 |
2001-11-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
JP2004506722A
(ja)
*
|
2000-08-23 |
2004-03-04 |
イーライ・リリー・アンド・カンパニー |
ペルオキシソーム増殖因子活性化受容体の調節方法
|
MXPA03001558A
(es)
*
|
2000-08-23 |
2003-06-06 |
Lilly Co Eli |
Agonistas del receptor activado del proliferador de peroxisoma.
|
ES2288982T3
(es)
*
|
2000-08-23 |
2008-02-01 |
Eli Lilly And Company |
Derivados de acido oxazolil-ariloxiacetico y su uso como agonistas ppar.
|
IL158589A0
(en)
|
2001-05-15 |
2004-05-12 |
Hoffmann La Roche |
Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
|
EE200400001A
(et)
|
2001-06-07 |
2004-02-16 |
Eli Lilly And Company |
alfa-metoksütsinnamaadid, nende valmistamine ja kasutamine peroksisoomi proliferaator-aktiveeritud retseptorite moduleerimiseks ning neid sisaldavad ravimkompositsioonid
|
JP2005502600A
(ja)
*
|
2001-06-07 |
2005-01-27 |
イーライ・リリー・アンド・カンパニー |
ペルオキシソーム増殖因子活性化受容体(ppar)のモジュレーター
|
US6987123B2
(en)
*
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US20030055076A1
(en)
*
|
2001-07-30 |
2003-03-20 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
PT1424330E
(pt)
*
|
2001-08-10 |
2011-12-22 |
Nippon Chemiphar Co |
Activador do receptor ä responsivo a proliferadores peroxissomais
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
FR2830012B1
(fr)
*
|
2001-09-21 |
2003-10-31 |
Servier Lab |
Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharamaceutiques qui les contiennent
|
DE60232739D1
(de)
*
|
2001-10-12 |
2009-08-06 |
Nippon Chemiphar Co |
Aktivator des peroxisomproliferator-aktivierten rezeptors delta
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
SE0104333D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
ITRM20020016A1
(it)
*
|
2002-01-15 |
2003-07-15 |
Sigma Tau Ind Farmaceuti |
Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
WO2004005266A1
(en)
*
|
2002-07-03 |
2004-01-15 |
F. Hoffmann-La Roche Ag |
Oxazole derivatives and their use as insulin sensitizers
|
AU2003263814A1
(en)
*
|
2002-07-26 |
2004-02-16 |
Bayer Pharmaceuticals Corporation |
Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
PT1537091E
(pt)
*
|
2002-08-30 |
2010-11-11 |
Hoffmann La Roche |
Novos compostos de 2-ariltiazole como agonistas de ppar-alfa e de ppar-gama
|
CN100577660C
(zh)
*
|
2002-09-12 |
2010-01-06 |
霍夫曼-拉罗奇有限公司 |
作为ppar激动剂用于治疗糖尿病的n-取代-1h-吲哚-5-丙酸化合物
|
AR041481A1
(es)
|
2002-10-07 |
2005-05-18 |
Hoffmann La Roche |
Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
|
AU2003276234B2
(en)
|
2002-11-08 |
2007-04-19 |
F. Hoffmann-La Roche Ag |
Substituted 4-alkoxyoxazol derivatives as PPAR agonists
|
BR0315713A
(pt)
*
|
2002-11-15 |
2005-09-13 |
Cadila Healthcare Ltd |
Composto, processo para a preparação do composto, composição farmacêutica, métodos para reduzir a glicose, para a prevenção ou para o tratamento de doenças e uso do composto
|
WO2004048371A1
(en)
*
|
2002-11-25 |
2004-06-10 |
F.Hoffmann-La Roche Ag |
Indolyl derivatives
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
DE602004010889T2
(de)
*
|
2003-02-14 |
2008-12-11 |
Eli Lilly And Co., Indianapolis |
Sulfonamid-derivate als ppar-modulatoren
|
CA2523808A1
(en)
*
|
2003-05-16 |
2004-12-23 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
US20040248972A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
JP2005008631A
(ja)
*
|
2003-05-29 |
2005-01-13 |
New Industry Research Organization |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
US7638540B2
(en)
|
2003-05-29 |
2009-12-29 |
The New Industry Research Organization |
Benzofuran compound and medicinal composition containing the same
|
GB0314131D0
(en)
*
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB2414294B
(en)
|
2004-05-20 |
2006-08-02 |
Teraview Ltd |
Apparatus and method for investigating a sample
|
KR101233223B1
(ko)
*
|
2004-12-21 |
2013-02-14 |
제이엔씨 석유 화학 주식회사 |
크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
|
ZA200800892B
(en)
*
|
2005-07-06 |
2009-04-29 |
Nippon Chemiphar Co |
Activator of peroxisome proliferator activated receptor δ
|
US7820721B2
(en)
|
2006-01-25 |
2010-10-26 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
CN101466687B
(zh)
*
|
2006-04-18 |
2012-04-11 |
日本化学医药株式会社 |
过氧化物酶体增殖剂激活受体δ的激活剂
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2721339C
(en)
*
|
2008-04-15 |
2017-01-24 |
Nippon Chemiphar Co., Ltd. |
Activating agent for peroxisome proliferator activated receptor
|
WO2011005875A1
(en)
*
|
2009-07-07 |
2011-01-13 |
Firestar Engineering Llc |
Detonation wave arrestor
|
WO2011020001A2
(en)
*
|
2009-08-14 |
2011-02-17 |
Cerenis Therapeutics S.A. |
Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases
|
GB201002243D0
(en)
*
|
2010-02-10 |
2010-03-31 |
Argenta Therapeutics Ltd |
Respiratory disease treatment
|
CN101941950B
(zh)
*
|
2010-08-05 |
2012-12-26 |
上海交通大学 |
2-取代苯并[d]噁唑-5-丙酸化合物及其制备和应用
|
WO2012104869A1
(en)
|
2011-01-31 |
2012-08-09 |
Cadila Healthcare Limited |
Treatment for lipodystrophy
|
KR101617812B1
(ko)
|
2013-04-22 |
2016-05-03 |
카딜라 핼쓰캐어 리미티드 |
비알콜성 지방간 질환을 위한 신규 조성물
|
US20160107989A1
(en)
|
2013-05-30 |
2016-04-21 |
Cadila Healthcare Limited |
A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
|
TW201513857A
(zh)
|
2013-07-05 |
2015-04-16 |
Cadila Healthcare Ltd |
協同性組成物
|
IN2013MU02470A
(pt)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
US10112898B2
(en)
|
2013-09-06 |
2018-10-30 |
Cadila Healthcare Limited |
Process for the preparation of saroglitazar pharmaceutical salts
|
EP3177285B1
(en)
*
|
2014-08-08 |
2020-09-23 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
WO2017064635A2
(en)
|
2015-10-14 |
2017-04-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
JP6840853B2
(ja)
|
2016-12-09 |
2021-03-10 |
カディラ・ヘルスケア・リミテッド |
原発性胆汁性胆管炎の治療
|